期刊文献+

肺部真菌感染诊断研究进展 被引量:5

下载PDF
导出
摘要 近20年来.随着器官移植免疫抑制剂的使用.癌症放疗化疗的增多.广谱抗菌药物的滥用和艾滋病的流行.免疫功能低下者不断增多。深部真菌感染作为一种并发病.感染率大幅上升.其中肺部真菌感染占深部真菌感染的首位.约50%~60%侵犯支气管、肺.以念珠菌和曲霉菌最常见.其次为新型隐球菌和毛霉菌。肺部真菌感染临床表现无特异性.早期诊断困难,病情常被原发病掩盖.易被误诊、漏诊.延误治疗时机;重症患者病死率高.据报道未经治疗的肺部真菌感染患者的病死率达30%~80%。因此.肺部真菌感染的早期诊断已经成为迫切需要解决的临床问题。近年来随着科学技术及实验手段的不断提高.由以往只靠痰液涂片、培养和组织病理学及影像学等检查手段来诊断肺部真菌感染的时期跨人免疫学、分子生物学检查的新时代.从而大大提高了肺部真菌感染的早期诊断率.也有利于临床合理使用抗真菌药物。
作者 安毛毛 王睿
出处 《临床药物治疗杂志》 2007年第2期50-53,41,共5页 Clinical Medication Journal
  • 相关文献

参考文献28

  • 1陈文彬.深部真菌感染病原学诊断概述[J].中国实用内科杂志,2002,22(1):5-6. 被引量:89
  • 2刘正印,盛瑞媛,李旭丽,李太生,王爱霞.院内真菌感染149例分析[J].中华医学杂志,2003,83(5):399-402. 被引量:153
  • 3[4]Verduyn Lunel FM,Meis JF,Voss A.Nosocomial fungal infections:candidemia.Diagn Microbiol Infect Dis,1999,34:213-220
  • 4[5]崔祥瑸,王鸣岐,萨藤三主编.实用肺脏病学.上海:上海科学技术出版社.1991.286-289
  • 5[6]Logan PM,Muller NL.CT manifestations of pulmonary aspergillosis.Crit Rev Diagn Imaging,1996,37:1-37
  • 6[7]Nagai H.Saprophytic and invasive pulmonary aspergillosis.Kekkaku,1997,72:99-107
  • 7[8]Won HJ,Lee KS,Cheon JE,et al.Invasive pulmonary aspergillosis:prediction at thin-section CT in patients with neutropenia-aprospective study.Radiology,1998,208:777-782
  • 8[9]Logan PM,Muller NL.High-resolution computed tomography and pathologic findings in pulmonary aspergillosis:a pictorial essay.Can Assoc Radiol J.1996,47:444-452
  • 9[10]Miyazaki T,Kohno S,Mitsutake K,et al.Plasma(1,3)-beta-D-glucan and fungal antigenemia in patients with candidemia,aspergillosis,and cryptococcosis.J Clin Micmbiol,1995,33:3115-3118
  • 10[11]Singh N,Paterson DL.Aspergillus infections in transplant recipients:Clin Microbiol Rev,2005,18:44-69

二级参考文献22

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2杜斌,张海涛,陈德昌,刘大为,侯百东,熊雯,刘彤华,陈杰.3447例尸检病例的深部真菌感染分析[J].中华医学杂志,1996,76(5):352-354. 被引量:119
  • 3Jarvis WR . Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis, 1995,20:1526-1530.
  • 4Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis, 1999,29:1164-1170.
  • 5Verduyn Lunel FM, Meis JF, Voss A, et al. Nosocomial fungal infections:candidemia. Diagn Microbiol Infect Dis, 1999,34:213-220.
  • 6Edmond MB, Wallace SE, McClish DK,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis, 1999,29: 239-244.
  • 7Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990.National Nosocomail Infections Surveillance System . J Infect Dis, 1993, 167:1247-1251.
  • 8Haddad NE, Powderly WG. The changing face of mycoses in patients with HIV/AIDS. AIDS Read, 2001,11: 375-378.
  • 9Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis, 1995,21:994-996.
  • 10Pfalller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis, 1999,33:217-222.

共引文献1066

同被引文献31

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部